Five-Day Event from October 12 to 16

Daewon Pharmaceutical announced on October 7 that it will hold an online comprehensive academic symposium, "D-Talks AGORA WEEK," for healthcare professionals nationwide from the 12th to the 16th.


D-Talks is Daewon Pharmaceutical's medical information exchange platform established in 2022. AGORA WEEK, held twice a year in the first and second halves, is a signature program that provides academic content focused on supporting medical practice for clinicians in private hospitals.


Daewon Pharmaceutical will hold an online comprehensive academic symposium called 'D-Talks AGORA WEEK' for healthcare professionals nationwide from the 12th to the 16th. Daewon Pharmaceutical

Daewon Pharmaceutical will hold an online comprehensive academic symposium called 'D-Talks AGORA WEEK' for healthcare professionals nationwide from the 12th to the 16th. Daewon Pharmaceutical

View original image

This second-half AGORA WEEK will feature sessions where experts in each field respond directly to questions submitted in advance. All lectures will be streamed daily at 1:00 p.m. so that medical professionals can watch them during their lunch break.


On the first day, October 12, the latest guidelines on Helicobacter pylori eradication will be covered. On the 13th, lectures will focus on real-world case studies related to nasal and throat diseases. On the 14th, key changes in hypertension management guidelines and blood pressure control will be discussed, followed by understanding and treatment of menopause on the 15th, and, on the final day, October 16, lectures will address spinal disorders and lower back pain management.


All AGORA WEEK lectures are available to D-Talks members of Daewon Pharmaceutical, who can watch them free of charge by accessing the online platform.



A representative of Daewon Pharmaceutical stated, "We will continue to provide digital academic content that offers real value to healthcare professionals."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing